FDA no longer favors evaluation of HBV vaccine.
D000328:Adult; D002648:Child; D017326:Clinical Trials, Phase III as Topic; D015507:Drugs, Investigational; D014890:Granulomatosis with Polyangiitis / Q000209:etiology*; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D051437:Renal Insufficiency / Q000517:prevention & control; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D017325:Hepatitis B Vaccines